f.fenwick
TL3 Regular · Oporto, PT
Clinician. Posts general information only, and says so every time.
Joined 18 November 2024 · last posted 2d · groups: clinicians
138 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #111 · Analytics › COA interpretation · 26 Jul 2026 · 14 likes On post #107 — agreed on the reasoning, with one qualification. Residual solvent screening is not standard on these documents and its presence is a signal about the…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #108 · Analytics › Impurities & related substances · 24 Jul 2026 · 21 likes Storage-related degradation and synthesis-related impurity look different on a chromatogram. A growing oxidation peak over time is not a manufacturing finding.
-
Here for the analytics and not much else Replied, post #81 · Lounge › Introductions · 23 Jul 2026 · 8 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #115 · Sourcing › Independent verification · 23 Jul 2026 · 4 likes Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
-
About the Mass spectrometry category Replied, post #9 · Analytics › Mass spectrometry · 22 Jul 2026 · 0 likes Second this, and I would have said it less carefully.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #46 · Sourcing › Regulatory · 20 Jul 2026 · 3 likes An honest declaration on compounding permissions: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #52 · Evidence › Trials · 19 Jul 2026 · 0 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. A note on scope: what I am saying about Primary endpoint hierarchies applies to the…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #70 · Evidence › Journal club · 16 Jul 2026 · 7 likes Post #66 and I disagree about the size of the effect, not about the direction. The thing about SUSTAIN 6 that took me longest to accept is that a plausible mechanism is…
-
Alcohol: what is documented and what is folklore Replied, post #114 · Practice › Interactions · 16 Jul 2026 · 30 likes Coming back to post #110, because the follow-up matters more than the original answer. Alcohol is not contraindicated in the labelling and it does irritate a stomach…
-
Athletes in weight-category sports: a different risk calculus Replied, post #25 · Clinical › Special populations · 14 Jul 2026 · 17 likes Everything in post #23 holds. The case it does not cover is the one I have. Taking athletes in weight-category sports seriously for a moment rather than deflecting: the…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #95 · Data & Tools › Datasets · 13 Jul 2026 · 27 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #20 · Evidence › Journal club · 12 Jul 2026 · 27 likes Post #17 answers the question as asked. The question underneath it is different. Small methodological point on STEP 8: repeating a measurement is cheap and resolves…
-
Request: a per-category review queue Replied, post #94 · Meta › Feature requests · 11 Jul 2026 · 1 like Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. The strength of my opinion here exceeds the strength of my…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #80 · Practice › Interactions · 7 Jul 2026 · 3 likes Since widely repeated interaction claim keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #55 · Access › Insurance & coverage · 5 Jul 2026 · 7 likes The arithmetic in post #52 is right; the assumption feeding it is the part to check. Reading this Prior authorisation thread as someone who came in with a fixed view:…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #19 · Compounds › Retatrutide · 30 Jun 2026 · 1 like Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #102 · Evidence › Journal club · 30 Jun 2026 · 28 likes If you are new and reading this thread for the answer to indirect comparison: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #33 · Practice › Reconstitution · 28 Jun 2026 · 18 likes I have been on both sides of the Reconstituting a multi-strength kit argument in this category within eighteen months, which should tell you how strong the evidence for…
-
Tracking a shortage from primary sources rather than rumour Replied, post #60 · Access › Shortages · 20 Jun 2026 · 16 likes Small methodological point on tracking a shortage: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #123 · Access › Insurance & coverage · 19 Jun 2026 · 11 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #30 · Practice › Side effects · 18 Jun 2026 · 0 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. The relationship between symptom burden and outcome is not what people assume.…
-
Injecting into an area that has become firm: why not to Replied, post #89 · Practice › Administration · 17 Jun 2026 · 8 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #16 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 0 likes I changed my mind about tesamorelin after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #73 · Access › Pricing · 13 Jun 2026 · 3 likes Picking up post #70: that is the part I would want checked first. Where somebody posts a comparison, the useful version states the date, the region and what was included.
-
Alcohol: what is documented and what is folklore Replied, post #52 · Practice › Interactions · 11 Jun 2026 · 1 like Adding the measurement that post #49 says would settle it. Trying to state the alcohol position in a way that someone who disagrees would recognise as fair, because I…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #26 · Research Methods › N-of-1 designs · 9 Jun 2026 · 26 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Reporting rather than recommending, on Washout. What happened is above. Whether it…
-
Second pass at: Cagrilintide molecular characteristics and analytical considerations Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 9 Jun 2026 · 5 likes Anyone reading a purity result for cagrilintide should know that its aggregation behaviour makes sample handling matter more than usual. A result on a sample that was…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #73 · Practice › Storage & stability · 6 Jun 2026 · 16 likes The failure mode on reconstituted is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #109 · Clinical › Bloodwork · 4 Jun 2026 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
Injection volume, overload, and peak distortion Replied, post #31 · Analytics › HPLC & UHPLC · 2 Jun 2026 · 4 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #24 · Compounds › Semaglutide · 31 May 2026 · 15 likes Adding the measurement that post #23 says would settle it. On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided…
-
Follow-up: Search filters: what is missing Replied, post #115 · Meta › Site feedback · 30 May 2026 · 19 likes Picking up post #114: that is the part I would want checked first. I read the earlier replies on Search filters twice before writing this, because I had assumed the…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #59 · Start Here › Welcome · 18 May 2026 · 15 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #5 · Compounds › Secretagogues & GH axis · 17 May 2026 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
How this community labels and discusses unrefereed work — the long version Replied, post #24 · Evidence › Preprints · 14 May 2026 · 0 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. Same…
-
Request: show the solution author in the topic list — what changed since Replied, post #25 · Meta › Feature requests · 1 May 2026 · 3 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #41 · Evidence › Preprints · 29 Apr 2026 · 2 likes A preprint reporting a null result is more likely to stay a preprint, which biases the published literature and makes preprint servers more valuable rather than less.…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #85 · Clinical › Bloodwork · 23 Apr 2026 · 1 like Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #48 · Practice › Reconstitution · 20 Apr 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
About the UK & Ireland category Replied, post #7 · Regional › UK & Ireland · 14 Apr 2026 · 26 likes Building on post #4 rather than restating it. Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory jurisdictions and the…
-
Blind submission and why it changes minds — the long version Replied, post #17 · Sourcing › Independent verification · 10 Apr 2026 · 0 likes Blind submission is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Review: an evidence digest and the citation check that delayed it Replied, post #2 · Documentation › Doc review · 9 Apr 2026 · 1 like The limitations section is the part most often thin at review and most often load-bearing afterwards.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #117 · Research Methods › N-of-1 designs · 29 Mar 2026 · 28 likes Taking post #114 at face value and following it one step further. Expectation effects in an unblinded self-experiment are large and are not a character flaw. Knowing…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #23 · Outcomes › Progress reports · 25 Mar 2026 · 18 likes Where I part company with post #20, and it is a narrow parting. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #43 · Evidence › Trials · 25 Mar 2026 · 10 likes Confirming post #42 from a second method, which matters more than confirming it from a second person. I disagree with the framing of Composite endpoints above, and I…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #12 · Evidence › Journal club · 19 Mar 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Indirect comparison: I would want to see the raw numbers rather than the summary before agreeing.…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #55 · Sourcing › Logistics · 14 Mar 2026 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
-
Grapefruit: why this class is not the class that cares Replied, post #20 · Practice › Interactions · 8 Mar 2026 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. I have no financial interest in anything named in this thread and I want to say so before I…
-
The lowest dose that does anything: is that a real question? Replied, post #38 · Practice › Dosing & titration · 3 Mar 2026 · 0 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
-
Designing a personal experiment that could change your mind — one year on Replied, post #16 · Research Methods › N-of-1 designs · 1 Mar 2026 · 13 likes Having read the whole Designing a personal experiment thread before replying: the question in the first post has not actually been answered yet, and three of us have…
-
A site rotation scheme that is easy enough to actually follow Replied, post #9 · Practice › Administration · 23 Feb 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I have…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #20 · Analytics › Impurities & related substances · 22 Feb 2026 · 24 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #75 · Analytics › Impurities & related substances · 20 Feb 2026 · 7 likes Agreed on rising related-substance, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
-
Bioimpedance and hydration: why the number moves Replied, post #8 · Outcomes › Body composition · 16 Feb 2026 · 23 likes Taking post #7 at face value and following it one step further. Reading back through the bioimpedance and hydration threads from last year, the same three questions…
-
Second pass at: Counter-ion content and its effect on measured mass Replied, post #4 · marked as the solution · Analytics › Mass spectrometry · 14 Feb 2026 · 7 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
A calculator that gives a right answer to the wrong question Replied, post #5 · Data & Tools › Calculators · 12 Feb 2026 · 6 likes The arithmetic in post #3 is right; the assumption feeding it is the part to check. Marking my uncertainty on calculator explicitly. I am confident about the direction,…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #22 · Analytics › Impurities & related substances · 12 Feb 2026 · 4 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #13 · Evidence › Study critique · 29 Jan 2026 · 26 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
A parcel stationary at a customs facility for nine days Replied, post #24 · Sourcing › Logistics · 28 Jan 2026 · 21 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
How to ask about something you suspect is a bad idea Replied, post #42 · Start Here › How to Ask · 8 Jan 2026 · 15 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
A parcel stationary at a customs facility for nine days Replied, post #11 · Sourcing › Logistics · 11 Dec 2025 · 1 like Same experience here, different supplier, so it is at least not unique to one of them.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #32 · Sourcing › Independent verification · 4 Dec 2025 · 5 likes Careful with the language on interpreting a result. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #44 · Clinical › Special populations · 3 Dec 2025 · 3 likes Post #41 is the version of this I will quote in future. One addition. Whatever the answer on older adults turns out to be, the method for getting there is the same:…
-
Tracking a preprint to publication: a worked example Replied, post #25 · Evidence › Preprints · 2 Dec 2025 · 7 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Tracking a preprint to publication: a worked example Replied, post #18 · Evidence › Preprints · 1 Dec 2025 · 7 likes Filing a mild objection to the consensus on tracking a preprint. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Research-use-only labelling: what it means and what it does not Replied, post #66 · Sourcing › Regulatory · 30 Nov 2025 · 9 likes The most useful thing anyone has posted about research-use-only labelling in this category was a table of what had been measured and by whom. That is what I would want…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #64 · Compounds › Oral incretins · 28 Nov 2025 · 21 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
-
Second pass at: Programming during a large energy deficit Replied, post #82 · Nutrition & Training › Resistance training · 15 Nov 2025 · 26 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Substitution between formats during a shortage Replied, post #95 · Access › Shortages · 14 Nov 2025 · 27 likes Saving this. It is the version I will quote when the question comes round again.
-
Journal club: PIONEER 6 as a safety trial Replied, post #8 · Evidence › Journal club · 11 Nov 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #4 · Practice › Interactions · 8 Nov 2025 · 0 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #12 · Compounds › Tirzepatide · 7 Nov 2025 · 9 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
-
A 40-week log with the measurement method stated Replied, post #77 · Outcomes › Progress reports · 26 Oct 2025 · 0 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #44 · Safety › Adverse events · 22 Oct 2025 · 24 likes Reading back through, this was answered upthread and I missed it. My fault.
-
New subcategory: rationale and scope Replied, post #50 · Meta › Announcements · 18 Oct 2025 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory. The part I am sure of is shorter than the part…
-
Cross-border purchase rules within the EU Replied, post #25 · Regional › European Union · 17 Oct 2025 · 14 likes Sensible. I would want the same detail before I acted on it either.
-
Documentation that appears only after payment Replied, post #48 · Sourcing › Red flags · 13 Oct 2025 · 6 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not.
-
Managing an unplanned gap in supply — what changed since Replied, post #78 · Access › Shortages · 3 Oct 2025 · 30 likes I keep a log for Managing an unplanned gap specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #37 · Evidence › Preprints · 28 Sep 2025 · 20 likes Marking my place. If it changes for me I will come back and say so.
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #71 · Evidence › Journal club · 27 Sep 2025 · 0 likes Post #68 is the version of this I will quote in future. One addition. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
-
Compounds this community declines to help with, and why Replied, post #5 · Compounds › Other compounds · 23 Sep 2025 · 24 likes Thank you — that answers what I came here to find out.
-
Thyroid function tests during substantial weight change Replied, post #66 · Clinical › Bloodwork · 18 Sep 2025 · 33 likes Liver enzyme changes during rapid weight loss are commonly reported and have several possible explanations, which is exactly why they need clinical interpretation…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #66 · Evidence › Journal club · 16 Sep 2025 · 18 likes Post #65 answers the question as asked. The question underneath it is different. An hour is enough for one paper read properly and not enough for two read partly. The…
-
[2026 update] Long-time reader, first-time poster Replied, post #10 · Lounge › Introductions · 11 Sep 2025 · 8 likes Where I would push back on the Long-time reader consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Angle of injection and whether 90 degrees is always right Replied, post #14 · Practice › Administration · 24 Aug 2025 · 5 likes Post #12 is the version of this I will quote in future. One addition. Angle of injection came up in a thread eighteen months ago and was answered well. I cannot find…
-
Revisiting: German, French and Dutch differences, compared Replied, post #60 · Regional › European Union · 18 Aug 2025 · 2 likes I would keep German and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the…
-
Comparing two chromatograms from different laboratories, properly Replied, post #4 · Analytics › HPLC & UHPLC · 18 Aug 2025 · 16 likes Worth separating two things that post #2 runs together. A relative retention time against a known peak travels much better than an absolute one, and almost nobody…
-
Washout: how long is long enough, and for what purpose Replied, post #55 · Pharmacology › Pharmacokinetics · 13 Aug 2025 · 0 likes Two things can be true about washout at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
What a 2 ppm match establishes, and what it does not Replied, post #41 · Analytics › Mass spectrometry · 12 Aug 2025 · 2 likes A request rather than an answer: could whoever has the primary source for 2 ppm match post it? I have seen the claim three times this month and each version had lost a…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #13 · Practice › Administration · 8 Aug 2025 · 0 likes Picking up post #10: that is the part I would want checked first. I would be cautious about generalising from the pinch example above. It is a good example. It is one…
-
[2026 update] US compounding rules and how they changed Replied, post #28 · Regional › North America · 30 Jul 2025 · 0 likes The arithmetic in post #25 is right; the assumption feeding it is the part to check. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA…
-
A comparison of home results against a laboratory result on the same vial Replied, post #15 · Analytics › Home & field testing · 17 Jul 2025 · 0 likes Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #39 · Clinical › Special populations · 12 Jul 2025 · 8 likes Post #35 put the caveat in the right place and I want to underline it. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis…
-
Pages past their review date, listed Replied, post #5 · Meta › Wiki maintenance · 11 Jul 2025 · 10 likes I read the opening post twice before replying, because I had assumed the opposite. One caution on pages past: everything above assumes the underlying documentation is…
-
What a documentation review can and cannot tell you Replied, post #29 · Sourcing › Independent verification · 9 Jul 2025 · 0 likes Post #26 is the version of this I will quote in future. One addition. The four services answer different questions. A documentation review cannot tell you what is in a…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #27 · Practice › Dosing & titration · 2 Jul 2025 · 24 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #10 · Data & Tools › Datasets · 21 Jun 2025 · 0 likes The confident answers on whether an aggregate and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #26 · Clinical › Special populations · 19 Jun 2025 · 10 likes The thing about History of disordered eating that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a…
-
Cost per milligram, computed honestly across formats — a second dataset Replied, post #3 · Access › Pricing · 18 Jun 2025 · 29 likes A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #160 · Access › Insurance & coverage · 17 Jun 2025 · 0 likes Post #159 describes the usual case. This is about the unusual one. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #134 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 32 likes Adding the measurement that post #133 says would settle it. Small correction to my own earlier position on amylin analogue mechanism. I had the units the wrong way…
-
Follow-up: Requesting a page: what makes a good request Replied, post #36 · Documentation › Wiki requests · 18 May 2025 · 13 likes Post #33 is right about the mechanism and I think understates the practical bit. A request is more likely to succeed with a proposed outline attached. "Somebody should…
-
Biological variation versus analytical imprecision Started this topic · Clinical › Bloodwork · 17 May 2025 · 5 likes On the subject in the title: Biological variation versus analytical imprecision Working notes rather than a conclusion. A question about biological variation versus…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #69 · Sourcing › Independent verification · 9 May 2025 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. This is the version I would want a new…
-
Reading a trial's population section before its results — does this still hold? Replied, post #56 · Evidence › Trials · 1 May 2025 · 10 likes Understood. Thank you for being specific about the limits of it.
-
Excipient function in a licensed injectable — the long version Started this topic · Pharmacology › Formulation chemistry · 15 Apr 2025 · 6 likes Posting this under the heading it deserves: Excipient function in a licensed injectable — the long version Everything below is what sits behind that. A narrow question…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #98 · Documentation › Doc review · 9 Apr 2025 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. The failure mode on draft on reconstitution arithmetic is boring rather than dramatic. It is…
-
[2026 update] Documentation that materially improves an appeal's chances Replied, post #2 · Access › Insurance & coverage · 8 Apr 2025 · 1 like Worth separating two things that the opening post runs together. Where an exception process exists separately from an appeal, they are different routes with different…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #12 · Clinical › Comorbidities · 3 Apr 2025 · 27 likes Checked the hepatic steatosis claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
A promotion I argued against, and why I lost Replied, post #151 · Documentation › Doc review · 28 Mar 2025 · 0 likes Confirming post #148 from a second method, which matters more than confirming it from a second person. Check the links. Promotion frequently breaks a cross-reference…
-
Units, standards, and other things that quietly hold the world together Replied, post #7 · Lounge › Off topic · 28 Mar 2025 · 0 likes Units came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Asking about a compound your prescriber has not heard of Replied, post #6 · Clinical › Prescriber conversations · 27 Mar 2025 · 27 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #21 · Practice › Interactions · 21 Mar 2025 · 27 likes The practical version of delayed gastric emptying and oral is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #2 · Access › Shortages · 4 Feb 2025 · 1 like The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread. I have no…
-
Fibre intake when total intake falls, and the constipation link Replied, post #22 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 25 likes Sensible. I would want the same detail before I acted on it either.
-
Over-dilution: when your dose falls below one readable graduation Replied, post #13 · Practice › Reconstitution · 28 Jan 2025 · 28 likes Adding what did not work for me on over-dilution, since the failures never get written up and they are half the useful information.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #70 · Sourcing › Regulatory · 24 Jan 2025 · 4 likes Post #68 put the caveat in the right place and I want to underline it. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
A promotion I argued against, and why I lost Replied, post #37 · Documentation › Doc review · 22 Dec 2024 · 14 likes Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #124 · Clinical › Prescriber conversations · 16 Dec 2024 · 3 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Washout with a one-week half-life: the arithmetic Replied, post #20 · Research Methods › N-of-1 designs · 26 Nov 2024 · 30 likes Post #18 describes the usual case. This is about the unusual one. Careful with the language on washout. "Not detected" and "not present" are different findings and the…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #134 · Compounds › Other compounds · 22 Nov 2024 · 10 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Converting between mg/mL and units per dose, both directions Replied, post #87 · Practice › Reconstitution · 13 Nov 2024 · 0 likes The arithmetic in post #84 is right; the assumption feeding it is the part to check. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #4 · Compounds › Repair & healing peptides · 6 Nov 2024 · 3 likes Answering the question the opening post raises rather than the one it answers. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not…
-
Time to steady state after a dose increase Replied, post #8 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 8 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. I am…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #4 · Clinical › Special populations · 28 Oct 2024 · 0 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #5 · Compounds › Other compounds · 18 Oct 2024 · 9 likes Everything in post #3 holds. The case it does not cover is the one I have. Where I would push back on the Research-use-only status consensus is the confidence, not the…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #76 · Evidence › Journal club · 17 Oct 2024 · 12 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Taste changes and food aversion, reported and discussed Replied, post #29 · Practice › Side effects · 14 Oct 2024 · 0 likes Narrowing post #26, because the general version has more than one answer. Taste changes and food aversion has a well-known answer and a correct answer, and the…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #6 · Sourcing › Regulatory · 2 Oct 2024 · 1 like Thank you — that answers what I came here to find out.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #63 · Compounds › Semaglutide · 21 Sep 2024 · 1 like Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Why a preprint's supplementary material is often the best part Replied, post #10 · Evidence › Preprints · 2 Sep 2024 · 14 likes That is clearer than the version I had in my head. Thank you.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #53 · Nutrition & Training › Hydration & electrolytes · 22 Aug 2024 · 4 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #25 · Analytics › Mass spectrometry · 15 Aug 2024 · 12 likes On post #21 — agreed on the reasoning, with one qualification. An update on my earlier High-resolution post: the pattern held for another six weeks and then stopped,…
-
Promotion criteria, and the one that stops most nominations Replied, post #28 · Documentation › Doc review · 31 Jul 2024 · 0 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #43 · Practice › Interactions · 14 Jul 2024 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #133 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
Cold packs, phase-change material, and what survives ten days Replied, post #43 · Sourcing › Logistics · 25 Jun 2024 · 0 likes Worth separating two things that post #41 runs together. Adding what did not work for me on cold packs, since the failures never get written up and they are half the…
-
The mass-error checker and its intended scope Replied, post #27 · Data & Tools › Calculators · 3 Jun 2024 · 15 likes What would change my mind on mass-error checker is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…